Zacks Investment Research on MSN
Lilly Up 10% in a Month: Should You Buy, Sell or Hold the Stock?
Eli Lilly and Company’s LLY stock has risen 9.5% in a month, mainly due to the recent recovery in the pharma sector. The drug ...
Consistency of BMD gains presented at NAMS 2025 demonstrate EB613's efficacy in both young postmenopausal women and in women 10 years post-menopause Data further support EB613 potential as a first-in- ...
Zacks.com on MSN
Here's Why You Should Add OPKO Health Stock to Your Portfolio
OPK benefits from RAYALDEE momentum, strategic deals and advancing trials amid stiff competition and dependence risks.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback